Amini: The majority of these patients — except at this time stage 1 — will need systemic therapy as part of their therapy, whether it is in the locally advanced resectable or unresectable case or ...
Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA® (talazoparib), ...
Amini: They play a significant role in how we treat metastatic lung cancer. All patients with stage IV disease should have ...
To test whether AT2‑derived lipids are required for metastasis, the researchers selectively deleted Fasn in AT2 cells.
SAN FRANCISCO — Maintenance treatment with capecitabine (Xeloda) and bevacizumab (Avastin) significantly delayed disease progression, compared with observation, in patients with metastatic colorectal ...
Pfizer announces phase 3 TALAPRO-3 study of talzenna plus Xtandi significantly improves rPFS in metastatic prostate cancer: New York Friday, March 20, 2026, 09:00 Hrs [IST] Pfizer ...
Patients with leptomeningeal metastasis (LM) have historically had few treatment options. Now, researchers from The ...
When you have HR+/HER2– metastatic breast cancer, a big part of treatment includes monitoring the condition with routine scans, physical exams, and blood tests. But the type of testing you’ll need — ...
MedPage Today on MSN
Dual immunotherapy and liver perfusion delays progression in uveal melanoma
Ipilimumab-nivolumab also linked with better survival but more toxicity in small study ...
Company Served as Sponsor and Provided Operational Leadership for Study Conducted in Partnership with TGen and Virta ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results